Antibody breaks leukemia's hold, providing new therapeutic approach
- OPACC
- Nov 1, 2016
- 1 min read
Acute myeloid leukemia (AML) is an aggressive cancer known for drug resistance and relapse. In an effort to uncover new treatment strategies, researchers have discovered that a cell surface molecule known as CD98 promotes AML.
Read more here: https://www.sciencedaily.com/releases/2016/10/161028115152.htm
Comments